Application of lncRNA HOXD-AS2 as diagnostic marker for gastric cancer
A technology for diagnosing markers and gastric cancer, applied in the field of medical biological detection, can solve problems such as unclear abnormal regulation of lncRNA signaling pathways, and achieve the effects of good translational medicine prospects, high sensitivity, and guaranteed reliability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0071] The relative expression levels of lncRNA HOXD-AS2 in gastric cancer tissues and corresponding paracancerous tissues were tested, and the results were as follows: figure 1 It can be seen from the figure that the relative expression level of lncRNA HOXD-AS2 in gastric cancer tissues is significantly lower than that in corresponding paracancerous tissues.
Embodiment 2
[0073] The relative expression levels of lncRNA HOXD-AS2 in five gastric cancer cell lines AGS, MGC-803, SGC-7901, BGC-823, SNU-1 and normal gastric mucosal cell GES-1 were tested, and the results were as follows: figure 2 shown.
[0074] It can be seen from the figure that the relative expression level of HOXD-AS2 in gastric cancer cell lines AGS, MGC-803, SGC-7901, BGC-823 and SNU-1 was significantly lower than that in normal gastric mucosal cell GES-1.
Embodiment 3
[0076] The expression level of lncRNA HOXD-AS2 in 79 gastric cancer patients was detected, and the relationship between the expression level of lncRNA HOXD-AS2 and the clinical data of gastric cancer patients is shown in Table 1 below.
[0077] Table 1 The relationship between the expression level of lncRNA HOXD-AS2 and the clinicopathological features of patients with gastric cancer
[0078]
[0079]
[0080] The low expression of HOXD-AS2 was related to lymph node metastasis (P=0.009) and TNM stage (P=0.040), but was related to gender, age, smoking, drinking, tumor diameter, degree of differentiation, depth of tumor invasion, distant Metastasis, vascular invasion, nerve invasion, liver metastasis, ascites and fat nodule metastasis were all irrelevant (P>0.050).
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com